Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
NCT06744660
This study is recruiting at 3 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The Metrix COVID Test will be evaluated for use in Point-of-Care and Non-Laboratory settings in a home testing environment utilizing the clinical study design described herein. The study will take place in simulated home environments which will be set up within or near active clinical settings (e.g., urgent care facilities). This will be a prospective study conducted at three or more investigational sites located within the United States for the clinical validation of the Metrix COVID Test for the detection of SARS-CoV-2 AN swab samples.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- COVID-19
- COVID
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 2 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Aptitude Medical Systems
- Last updated on ClinicalTrials.gov
- October 2, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 2
- AFC Montclair · Birmingham, AL
- AFC Madison · Madison, AL
Louisiana · 1
- PPU Mid City · Baton Rouge, LA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.